Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EZZ | Ann: EZZ Completes Private Placement with Strategic Investor | 16/04/24 | 22 | 3.2K | |||
|
|||||||
EZZ | Ann: Notice under Section 708A(5)(e) of the Corporations Act 2001 | 15/04/24 | 0 | 111 | |||
|
|||||||
EZZ | Ann: Application for quotation of securities - EZZ | 15/04/24 | 0 | 108 | |||
|
|||||||
EZZ | Ann: Proposed issue of securities - EZZ | 12/04/24 | 0 | 141 | |||
|
|||||||
EZZ | Ann: Investor Presentation 1H FY24 and Market Update | 11/04/24 | 39 | 7.0K | |||
|
|||||||
EZZ | News: EZZ Ezz Life Science Posts HY Revenue A$21.7M | 27/03/24 | 0 | 127 | |||
|
|||||||
EZZ | Ann: Half Yearly Report and Accounts | 27/03/24 | 20 | 3.7K | |||
|
|||||||
EZZ | Ann: Quarterly Activities/Appendix 4C Cash Flow Report | 28/02/24 | 36 | 7.3K | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |